Abstract
In the previously reported arylthiazole antibiotics the lipophilic part of the n-butylphenyl moiety was replaced with naphthyl ring which improved its activity against Vancomycin resistant strains of Staphylococcus aureus. In the other hand, the incorporation of the C=N linker connecting the nitrogenous head with thiazole within an oxadiazole ring provided orally available analogs with relatively long half-life. New eight derivatives of 2-(thiazol-5-yl)-1,3,4-oxadiazole was synthesized by combining both structural modifications in one new scaffold to enhance the pharmacokinetic profile and antibacterial activities against malicious microbes, two of them is comparably potent as Vancomycin.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
